Pancreatic Cancer Research

ResearcherSamsung Medical CenterNo recent work listed

Yeon Jeong Kim

ORCID-verified (high confidence)As of 10 November 2026

Matched on ORCID iD 0000-0003-3297-9463; OpenAlex author ID A5010192735.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Collaborators
9
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper

Papers 3

  1. Utility of targeted deep sequencing for detecting circulating tumor DNA in pancreatic cancer patients. Co-author DOI 10.1038/s41598-018-30100-w↗
  2. Inhibition of checkpoint kinase 2 (CHK2) enhances sensitivity of pancreatic adenocarcinoma cells to gemcitabine. Co-author DOI 10.1111/jcmm.12101↗
  3. Transforming growth factor beta receptor I inhibitor sensitizes drug-resistant pancreatic cancer cells to gemcitabine. First author PMID 22399597↗

Closest collaborators

The 9 strongest of 9 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Gahee Park · 1 shared paper, 2018
  2. Joo Kyung Park · 1 shared paper, 2018
  3. Kwang Hyuck Lee · 1 shared paper, 2018
  4. Donghyun Park · 1 shared paper, 2018
  5. Insoo Bae · 2 shared papers, 2012–2013
  6. Young Bin Hong · 2 shared papers, 2012–2013
  7. Yeon-Sun Seong · 2 shared papers, 2012–2013
  8. Yong Weon Yi · 1 shared paper, 2013
  9. Hong-Quan Duong · 1 shared paper, 2013

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.